Aura Biosciences (AURA) Change in Account Payables (2020 - 2026)
Aura Biosciences filings provide 7 years of Change in Account Payables readings, the most recent being $1.0 million for Q1 2026.
- Quarterly Change in Account Payables rose 443.62% to $1.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $476000.0 through Mar 2026, up 195.65% year-over-year, with the annual reading at -$846000.0 for FY2025, 275.52% down from the prior year.
- Change in Account Payables hit $1.0 million in Q1 2026 for Aura Biosciences, up from -$430000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.0 million in Q1 2026 and bottomed at -$1.9 million in Q1 2023.
- Average Change in Account Payables over 5 years is -$2352.9, with a median of $23000.0 recorded in 2024.
- The largest annual shift saw Change in Account Payables surged 524.54% in 2022 before it plummeted 1395.65% in 2025.
- Aura Biosciences' Change in Account Payables stood at $1.0 million in 2022, then crashed by 55.11% to $457000.0 in 2023, then crashed by 32.17% to $310000.0 in 2024, then crashed by 238.71% to -$430000.0 in 2025, then skyrocketed by 338.14% to $1.0 million in 2026.
- Per Business Quant, the three most recent readings for AURA's Change in Account Payables are $1.0 million (Q1 2026), -$430000.0 (Q4 2025), and $602000.0 (Q3 2025).